Dr. Paul Rubinstein, MD
Claim this profileUniversity of Illinois
Area of expertise
Lymphoma
Paul Rubinstein, MD has run 10 trials for Lymphoma. Some of their research focus areas include:
Diffuse Large B-Cell Lymphoma
Paul Rubinstein, MD has run 4 trials for Diffuse Large B-Cell Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
University Of Illinois
University Of Illinois At Chicago
Clinical Trials Paul Rubinstein, MD is currently running
Daratumumab + Chemotherapy
for Lymphoma
This trial studies how well daratumumab combined with chemotherapy works in treating patients with a specific type of lymphoma. The treatment targets cancer cells with a protein called CD38, helping the immune system attack them and stopping their growth. Daratumumab is a CD38 monoclonal antibody approved for treating relapsed/refractory and newly diagnosed multiple myeloma.
Recruiting
1 award
Phase < 1
10 criteria
AVM0703
for Lymphoma
This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.
Recruiting
1 award
Phase 1 & 2
6 criteria
More about Paul Rubinstein, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Paul Rubinstein, MD has experience with
- Cyclophosphamide
- Etoposide
- Prednisone
- Ibrutinib
- Rituximab
- Vincristine Sulfate
Breakdown of trials Paul Rubinstein, MD has run
Lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Lymphoma
Follicular Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Rubinstein, MD specialize in?
Paul Rubinstein, MD focuses on Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Paul Rubinstein, MD currently recruiting for clinical trials?
Yes, Paul Rubinstein, MD is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Paul Rubinstein, MD has studied deeply?
Yes, Paul Rubinstein, MD has studied treatments such as Cyclophosphamide, Etoposide, Prednisone.
What is the best way to schedule an appointment with Paul Rubinstein, MD?
Apply for one of the trials that Paul Rubinstein, MD is conducting.
What is the office address of Paul Rubinstein, MD?
The office of Paul Rubinstein, MD is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.